Vaxneuvance Description

1 dose (0.5 mL) contains: Pneumococcal polysaccharide serotype 1^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 3^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 4^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 5^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 6A^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 6B^1,2 4.0 micrograms; Pneumococcal polysaccharide serotype 7F^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 9V^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 14^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 18C^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 19A^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 19F^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 22F^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 23F^1,2 2.0 micrograms; Pneumococcal polysaccharide serotype 33F^1,2 2.0 micrograms.
¹ Conjugated to CRM₁₉₇ carrier protein. CRM₁₉₇ is a nontoxic mutant of diphtheria toxin (originating from Corynebacterium diphtheriae C7) expressed recombinantly in Pseudomonas fluorescens.
² Adsorbed on aluminium phosphate adjuvant.
1 dose (0.5 mL) contains 125 micrograms aluminium (Al³⁺) and approximately 30 micrograms CRM₁₉₇ carrier protein.
Excipients/Inactive Ingredients: Sodium chloride (NaCl), L-histidine, Polysorbate 20, Water for injections.